This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Novartis Ag. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: Nguyen Tan - Innovator in Melanoma Treatment
Introduction
Nguyen Tan is a notable inventor based in San Leandro, CA (US). He has made significant contributions to the field of melanoma treatment through his innovative research and patent.
Latest Patents
Nguyen Tan holds a patent titled "Use of melanoma inhibitory activity (MIA) protein as an early indicator for therapeutic response in melanoma." This invention provides a method for determining the response of a mammalian subject with melanoma tumor cells to treatment with a melanoma inhibitory agent. The method involves determining the concentration of melanoma inhibitory activity protein (MIA) in biological samples taken before and after treatment. A decrease in MIA concentration after treatment indicates a positive response to the therapy.
Career Highlights
Nguyen Tan is associated with Novartis AG, a leading global healthcare company. His work focuses on advancing therapeutic strategies for melanoma, contributing to the development of effective treatment protocols.
Collaborations
Nguyen has collaborated with esteemed colleagues such as Eleni Venetsanakos and Michel Faure, enhancing the research efforts in melanoma treatment.
Conclusion
Nguyen Tan's innovative approach to melanoma treatment through his patented method showcases his dedication to improving patient outcomes. His contributions to the field are invaluable and highlight the importance of ongoing research in cancer therapies.